Compare Entegris Inc (ENTG) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Entegris Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Entegris Inc trades at $151.3 (market cap $24.63B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Entegris Inc is far larger — about 2.9× Hinge Health Inc. Class A Common Stock's market cap, and Entegris Inc pays a 0.25% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Entegris Inc for 41 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| ENTG | HNGE | |
|---|---|---|
Market Cap | $24.63B | $8.48B |
Volume | 2,062,440 | 879,799 |
Sector | Technology | Health |
52-Week High | $184.00 | $105.14 |
52-Week Low | $68.80 | $31.17 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | $27.83B | $8.10B |
Dividend Yield | 0.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Entegris (ENTG) trades at $153.08, down 4.33% amid broader market weakness, yet maintains strong analyst support with a $186.56 consensus price target. The semiconductor materials company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.93 surpassing expectations by 13%. Technical indicators show a bullish moving average trend while fundamentals reveal elevated valuation metrics (P/E 80.58) offset by robust profitability (9.18% net margin) and positive cash flow generation.
Investment outlook remains favorable given Entegris's positioning in high-growth semiconductor segments and AI-driven demand, though valuation concerns and debt levels warrant monitoring. The stock offers 22% upside to consensus targets but faces execution risks in a cyclical industry. Recent institutional accumulation and patent defense successes provide additional confidence in the company's competitive moat.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Entegris Inc
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
